A fifty-three-year-old accountant in Lekki, two years past her final period, has been told by her gynaecologist to watch her weight and by her personal trainer at a gym off Admiralty Way to do more cardio classes and pilates because she does not want to look bulky. She trains four mornings a week, eats carefully, weighs almost exactly what she weighed at forty-eight. She is, by every reading her current care produces, doing well. The DEXA scan her gynaecologist did not order, but which she paid for herself in March after reading something on a foreign website, returned a T-score of minus 2.3 at her lumbar spine and minus 2.1 at her left femoral neck. She is osteopenic crossing into osteoporotic. She is, by the actuarial reading of those numbers, one fall away from a vertebral fracture that will reorganise the next twenty years of her life. Nobody in her current care has prescribed the intervention the international literature now places first for the disease she has.
This is not hypothetical. The pattern — the responsible exercise habit, the careful eating, the cosmetic frame applied to a clinical problem, the missing prescription — is so consistent across her demographic that the composite reads more truthfully than any single case file. For the post-menopausal Nigerian woman, and increasingly for the perimenopausal woman in her forties, heavy resistance training is the single most evidence-based non-pharmaceutical intervention in modern medicine. The bone-density question used to be: which medication. It is now: which medication, alongside which resistance protocol. Almost no Nigerian woman in this demographic is being told.
This piece is for that woman, and for the physician who would have placed her DEXA result into a prescription the first time she described her training pattern.
What heavy lifting actually does for the post-menopausal woman
The cultural framing of women's strength training in Nigeria is almost entirely aesthetic. The gym in Ikoyi sells itself on tone, on definition, on a body shape that photographs well. The woman in her early fifties walking onto the floor is presumed to be there for the same reason a thirty-year-old is, only more discreetly. That framing is the single most expensive misunderstanding in Nigerian women's medicine over forty, because the biological effects of heavy resistance training in this demographic are not cosmetic. They are skeletal, metabolic, neuromuscular, and cardiovascular — precisely the effects most relevant to the diseases the post-menopausal Nigerian woman is statistically about to develop.
The headline effect is bone. The LIFTMOR trial, published by Watson and colleagues in the Journal of Bone and Mineral Research in 2018, randomised post-menopausal women with low bone mass to either eight months of supervised heavy resistance and impact training, twice a week, or to a home-based light-exercise control. The intervention group performed five sets of five repetitions of the back squat, conventional deadlift, and overhead press at eighty to eighty-five per cent of one-repetition maximum, alongside a small dose of high-impact loading — jumping chin-ups and stomps. The control group did what most Nigerian women of fifty-five are currently doing: light, low-impact, generic. At eight months, the intervention group had gained bone mineral density at the lumbar spine and femoral neck. The control group had lost density. The clinical result previously considered unachievable without bisphosphonates — meaningful BMD gain in post-menopausal women with osteopenia or osteoporosis, from exercise alone — was achieved by lifting heavy under competent supervision.
The mechanism is not new. Bone responds to load. The load required to produce an osteogenic response is meaningfully larger than the load delivered by a treadmill, a pilates reformer, or a three-kilogram dumbbell. What LIFTMOR established — and what the follow-up impact-training literature from Bolam, Beck, and others has reinforced — is that the required load is not so large that the demographic at highest risk from a fracture cannot tolerate it. The NAMS 2023 position statement and the IOF's exercise guidance now reflect this. Heavy resistance training, alongside impact, is first-line non-pharmacological care for post-menopausal bone health.
The second effect is muscle. Sarcopenia — the loss of skeletal muscle mass — accelerates through the menopausal transition and continues through the decades that follow. The clinical consequences are functional, not aesthetic. Grip strength, measurable in any consulting room with a cheap dynamometer, is one of the more reliable predictors of all-cause mortality in older women; the PURE cohort, reported by Leong and colleagues, established that each five-kilogram decrement in grip strength carried a measurable increase in mortality risk. Resistance training is the only intervention that meaningfully reverses sarcopenic muscle loss. Not protein supplementation alone, not aerobic exercise alone, not hormone therapy alone. The lift is what restores the muscle.
The third effect is metabolic. Skeletal muscle is the body's largest insulin sink. Roughly seventy to eighty per cent of an insulin-mediated glucose load is disposed of through skeletal muscle, and the post-menopausal Nigerian woman — sitting at the intersection of declining oestrogen, declining muscle mass, and the population-level rise in Type 2 diabetes that hits her demographic in her sixties — is, in mechanical terms, losing her disposal sink at exactly the moment her endocrine context is most likely to overrun it. Resistance training rebuilds that sink. The diabetes she develops in her sixties, on the current trajectory, is in many cases a disease the lift would have delayed by a decade.
The remaining effects compound. The pre-menopausal cardiovascular advantage Nigerian women carry attenuates through the perimenopausal years and is largely gone by sixty; the AHA and ACSM now both prescribe combined aerobic and resistance training in this demographic, and the combined protocol consistently outperforms either modality alone. Resistance training also improves sleep architecture, reduces depressive symptoms, and produces modest gains in cognitive measures across controlled studies. None of this is fringe. It is the routine consensus reading of the last decade of literature.
A second patient
A forty-six-year-old senior public servant in Wuse, perimenopausal, has been told by her family doctor to lose ten kilograms. She has tried three times. Each time she lost roughly the amount asked for. Each time she rebound-gained more. She has been on a cycle of nutrition apps and cardio classes for six years and is, by waist-to-hip ratio and lean-mass measurement done properly, in worse cardiometabolic shape than she was when the conversation began.
The advice was about the number on the scale. The right advice was about the composition of the body the scale was measuring. The weight she lost each cycle was muscle alongside fat; the weight she regained was disproportionately fat. The asset she was meant to be protecting was the muscle. Her doctor never asked about her resistance training because resistance training was not part of the conversation he had been trained to have with a woman of her age. He asked about her diet, asked about her cardio, weighed her, looked disappointed at the number, and asked her to come back in three months. She is not unusual. She is the dominant pattern across her demographic.
A note on the safety question, which is the one most patients raise. The standard pushback — that heavy lifting is dangerous for older women — does not survive contact with the data. Injury rates in supervised resistance-training programmes in this population are low. The population at highest risk from a fall is the population at highest benefit from progressive load. Lifting heavy under competent supervision is, on every endpoint that has been measured, safer than not lifting at all.
Why Nigerian women's fitness culture has built around the wrong prescription
This is the part of the conversation the international literature does not have to have. In the gyms of Stockholm and Toronto, women in their fifties lift heavy. In Lagos and Abuja, with rare exception, they do not. Three cultural reasons compound.
The first is the aesthetic frame. Women's fitness in Nigeria is sold and consumed as a body-shape pursuit. The gyms are organised around it; the trainers are trained to deliver it. Bone density does not photograph. Sarcopenia reversal does not photograph. Femoral-neck BMD gain produces no before-and-after image a coach can put on Instagram. The intervention with the strongest evidence base for this demographic also has the weakest aesthetic theatre, and a market organised around aesthetic theatre will not voluntarily prescribe it.
The second is the bulking myth. The most common reason Nigerian women over forty give for not lifting heavy is the fear of looking bulky. The endocrinology says the fear is essentially unfounded. The post-menopausal woman has roughly one-fifteenth of the circulating testosterone a man has, declining further with age. The hypertrophic response to heavy lifting in this demographic, without pharmaceutical assistance, produces a stronger and more compositionally sound body — not the silhouette that lives in the fear. The myth survives because it is repeated by trainers who do not know the endocrinology.
The third is the gendered gym geography. The compound-lift platform in most Nigerian commercial gyms is occupied by men in their twenties and thirties. The cultural friction of a fifty-three-year-old woman walking onto that platform — in the gym her trainer has been steering her away from for two years — is real. Many gyms have not built a culture in which she is welcome there. A small but real number have. They are usually not the most expensive gyms — they are the powerlifting clubs and independent strength-coaching practices that have, almost incidentally, developed a clientele of older women because the coaching was competent and the door was open.
A third patient
A fifty-five-year-old educator in Garki, one of our members, came into a perimenopausal review eighteen months ago carrying the symptom load the menopause piece catalogues. The HRT conversation was held in the modern frame. The DEXA returned a T-score of minus 1.9 at the spine, minus 1.6 at the femoral neck. The exercise conversation was held in the LIFTMOR frame, not the generic-encouragement frame. She was introduced to a strength coach in Wuse who teaches the squat and the deadlift to clients who walk in having never held a barbell. The first six weeks were technique, with a near-empty bar. The first noticeable change, at three months, was sleep — depth of sleep she had not had in five years. Then mood. Then a quietness in her joints she had not realised she had been ignoring. At twelve months the repeat DEXA returned a T-score of minus 1.6 at the spine, minus 1.4 at the femoral neck. The density her previous trajectory had been losing each year was being recovered. She is what the protocol produces in an appropriately selected woman with a competent coach and a year.
What proper exercise prescription actually looks like for the Nigerian woman over forty
The clinical work, when done properly, is a sequence. A real workup first — DEXA in any woman with risk factors for osteoporosis, which is, in practice, every post-menopausal woman over fifty-five. A baseline lean-mass reading by bioelectrical impedance or DEXA composition. A grip-strength score against age-adjusted normals. Blood pressure, HbA1c, fasting insulin, vitamin D, calcium. Cheap, fast, revealing. The baseline against which the intervention will be measured.
A coach who has worked with this demographic. Not the personal trainer who has built a practice around twenty-three-year-olds. The strength coaches in Abuja and Lagos with meaningful experience teaching women over forty to squat and deadlift are usually attached to powerlifting clubs or independent strength-coaching practices rather than commercial chain gyms. They are not difficult to find. They are difficult to find without an introduction.
The protocol. Sets of five repetitions on the compound lifts — back squat, deadlift, overhead press, with bench or floor press depending on shoulder history — at a progressive load, twice weekly. Supervised one-to-one for the first three months while technique is established. Reassessed at six and twelve months on the markers that matter: DEXA, grip strength, lean mass. Not the scale. Bodyweight on this protocol is a poor proxy for what is happening underneath it.
The menopause piece made the case for the proper HRT conversation. This piece adds the case for the proper exercise conversation. They compound. The bone-density effects are additive in the literature; so are the metabolic, mood, and sleep effects. The post-menopausal Nigerian woman whose care includes both, where both are appropriate, is on a trajectory measurably different from the one her current care is on.
What is lost when the conversation does not happen
The Lekki accountant in the opening paragraph is not, on the evidence, being given the wrong advice through malice. She is being given the wrong advice because the conversation that would surface what she actually needs — the DEXA result reframed as the diagnosis of a treatable disease, the exercise prescription specified with the precision the literature now requires, the introduction to a coach who knows how to teach the lifts to a woman in her demographic — is not the conversation her gynaecologist has time for and not the conversation her trainer has been trained to hold. The cost is paid in the vertebral fractures she sustains in her early sixties, in the femoral fracture at sixty-eight she does not get back up from in the way she would have at sixty, in the diabetes she develops in her late sixties that the protocol would have delayed by a decade. The intervention exists. It is well-evidenced. Almost nobody in her current care is pointing her at it.
What Kinedic does about it
The annual physical for a female member over forty-five includes the conversation. Where DEXA is indicated, it is ordered, read, and explained. Where exercise is prescribed, it is prescribed specifically — not "stay active," not "try to walk more" — with a named coach, a written protocol, and reassessment at six and twelve months on the markers that matter. Bone density, grip strength, lean mass, fasting insulin, HbA1c. The trajectory across years of those numbers is the object of the work. The number on the scale is not.
The coaches we work with are coaches we know personally. The introduction is something we hold open on behalf of our members, because the gap between knowing what the protocol is and finding someone competent to teach it is the gap the demographic falls into when left to navigate the internet on its own.
Closing
The Nigerian woman of fifty-three reading this has, in 2026, access to a clinical intervention her mother did not have and her gynaecologist may not have raised with her — an intervention the modern literature considers first-line for the disease most likely to organise the second half of her life. She will, in most cases, be told by her trainer that she does not need to lift heavy, by her family that lifting heavy is for men or for a younger version of herself, and by her primary-care doctor in vague terms to stay active. The honest prescription is more specific than any of those. Twice a week. Compound lifts at meaningful load. Supervised, at first, by someone who has worked with women in her demographic. Reassessed annually against the biomarkers that matter. It is, on the evidence, the single most clinically valuable hour of her week for the next twenty years.
The physician's job is to make that hour possible. To order the DEXA. To read it. To write the prescription specifically. To introduce her to a coach worth her time. To follow up on it. The patient will resist the prescription; the doctor will be tempted to soften it; the cost of the softened version is the woman in the opening paragraph.
The first conversation is private and costs nothing.